v3.26.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Millions
Jun. 30, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 250.2 $ 292.5
Trade and other accounts receivable (less allowances of $15.4 million and $11.8 million respectively) 408.6 342.3
Inventories (less allowances of $42.5 million and $40.4 million respectively):    
Finished goods 235.0 226.3
Raw materials 102.3 103.0
Total inventories 337.3 329.3
Prepaid expenses 13.3 20.1
Prepaid income taxes 5.7 13.1
Other current assets 9.6 7.3
Total current assets 1,024.7 1,004.6
Net property, plant and equipment 293.3 286.1
Operating lease right-of-use assets 47.9 52.7
Goodwill 398.2 399.0
Other intangible assets 65.3 67.7
Deferred tax assets 13.3 13.6
Other non-current assets 3.5 8.7
Total assets 1,846.2 1,832.4
Current liabilities:    
Accounts payable 169.4 174.7
Accrued liabilities 170.0 152.3
Current portion of operating lease liabilities 14.3 15.9
Current portion of plant closure provisions 4.9 4.9
Current portion of acquisition-related contingent consideration 2.8 7.0
Accrued income taxes 6.7 5.3
Total current liabilities 368.1 360.1
Operating lease liabilities, net of current portion 33.6 36.8
Plant closure provisions, net of current portion 59.8 60.2
Deferred tax liabilities 16.0 19.1
Pension liabilities and post-employment benefits 12.7 13.2
Acquisition-related contingent consideration 1.3 1.3
Other non-current liabilities 3.7 8.8
Total liabilities 495.2 499.5
Equity:    
Common stock, $0.01 par value, authorized 40,000,000 shares, issued 29,554,500shares 0.3 0.3
Additional paid-in capital 379.1 376.5
Treasury stock (4,923,453 and 4,776,918 shares at cost, respectively) (127.8) (115.2)
Retained earnings 1,137.7 1,099.2
Accumulated other comprehensive loss (45.9) (34.7)
Total Innospec stockholders' equity 1,343.4 1,326.1
Non-controlling interest 7.6 6.8
Total equity 1,351.0 1,332.9
Total liabilities and equity $ 1,846.2 $ 1,832.4